These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 11682210)

  • 21. Recognition of a high-affinity phosphotyrosyl peptide by the Src homology-2 domain of p56lck.
    Eck MJ; Shoelson SE; Harrison SC
    Nature; 1993 Mar; 362(6415):87-91. PubMed ID: 7680435
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting Self-Binding Peptides as a Novel Strategy To Regulate Protein Activity and Function: A Case Study on the Proto-oncogene Tyrosine Protein Kinase c-Src.
    Bai Z; Hou S; Zhang S; Li Z; Zhou P
    J Chem Inf Model; 2017 Apr; 57(4):835-845. PubMed ID: 28345935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Src homology 2 domain substitution modulates the kinase and transforming activities of the Fes protein-tyrosine kinase.
    Rogers JA; Cheng HY; Smithgall TE
    Cell Growth Differ; 2000 Nov; 11(11):581-92. PubMed ID: 11095247
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Single phosphorylation of Tyr304 in the cytoplasmic tail of ephrin B2 confers high-affinity and bifunctional binding to both the SH2 domain of Grb4 and the PDZ domain of the PDZ-RGS3 protein.
    Su Z; Xu P; Ni F
    Eur J Biochem; 2004 May; 271(9):1725-36. PubMed ID: 15096211
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Src homology-2 domains protect phosphotyrosyl residues against enzymatic dephosphorylation.
    Brunati AM; Pinna LA; Bergantino E; Ruzzene M; Cirri P; Ramponi G; Donella-Deana A
    Biochem Biophys Res Commun; 1998 Feb; 243(3):700-5. PubMed ID: 9500984
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The amino-terminal Src homology 2 domain of phospholipase C gamma 1 is essential for TCR-induced tyrosine phosphorylation of phospholipase C gamma 1.
    Stoica B; DeBell KE; Graham L; Rellahan BL; Alava MA; Laborda J; Bonvini E
    J Immunol; 1998 Feb; 160(3):1059-66. PubMed ID: 9570517
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phosphatidylinositol 3-kinase p85 SH2 domain specificity defined by direct phosphopeptide/SH2 domain binding.
    Piccione E; Case RD; Domchek SM; Hu P; Chaudhuri M; Backer JM; Schlessinger J; Shoelson SE
    Biochemistry; 1993 Apr; 32(13):3197-202. PubMed ID: 8384875
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterizing SH2 Domain Specificity and Network Interactions Using SPOT Peptide Arrays.
    Liu BA
    Methods Mol Biol; 2017; 1555():357-373. PubMed ID: 28092043
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Rosette Assay: Highly Customizable Dot-Blot for SH2 Domain Screening.
    Ng KY; Machida K
    Methods Mol Biol; 2017; 1555():437-451. PubMed ID: 28092049
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Design of tetrapeptide ligands as inhibitors of the Src SH2 domain.
    Nam NH; Pitts RL; Sun G; Sardari S; Tiemo A; Xie M; Yan B; Parang K
    Bioorg Med Chem; 2004 Feb; 12(4):779-87. PubMed ID: 14759738
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Discovery of a novel nonphosphorylated pentapeptide motif displaying high affinity for Grb2-SH2 domain by the utilization of 3'-substituted tyrosine derivatives.
    Song YL; Peach ML; Roller PP; Qiu S; Wang S; Long YQ
    J Med Chem; 2006 Mar; 49(5):1585-96. PubMed ID: 16509576
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutational analysis of the regulatory function of the c-Abl Src homology 3 domain.
    Brasher BB; Roumiantsev S; Van Etten RA
    Oncogene; 2001 Nov; 20(53):7744-52. PubMed ID: 11753652
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Modulation of SHP-1 phosphatase activity by monovalent and bivalent SH2 phosphopeptide ligands.
    Teichmann K; Kühl T; Könnig I; Wieligmann K; Zacharias M; Imhof D
    Biopolymers; 2010 Jan; 93(1):102-12. PubMed ID: 19768778
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ligand specificity modulated by prolyl imide bond Cis/Trans isomerization in the Itk SH2 domain: a quantitative NMR study.
    Breheny PJ; Laederach A; Fulton DB; Andreotti AH
    J Am Chem Soc; 2003 Dec; 125(51):15706-7. PubMed ID: 14677936
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Role of electrostatic interactions in SH2 domain recognition: salt-dependence of tyrosyl-phosphorylated peptide binding to the tandem SH2 domain of the Syk kinase and the single SH2 domain of the Src kinase.
    Grucza RA; Bradshaw JM; Mitaxov V; Waksman G
    Biochemistry; 2000 Aug; 39(33):10072-81. PubMed ID: 10955995
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structural basis for domain-domain communication in a protein tyrosine kinase, the C-terminal Src kinase.
    Lin X; Wang Y; Ahmadibeni Y; Parang K; Sun G
    J Mol Biol; 2006 Apr; 357(4):1263-73. PubMed ID: 16483606
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Src homology 2 domain of the protein-tyrosine kinase p56lck mediates both intermolecular and intramolecular interactions.
    Amrein KE; Panholzer B; Flint NA; Bannwarth W; Burn P
    Proc Natl Acad Sci U S A; 1993 Nov; 90(21):10285-9. PubMed ID: 7694287
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro characterization of major ligands for Src homology 2 domains derived from protein tyrosine kinases, from the adaptor protein SHC and from GTPase-activating protein in Ramos B cells.
    Baumann G; Maier D; Freuler F; Tschopp C; Baudisch K; Wienands J
    Eur J Immunol; 1994 Aug; 24(8):1799-807. PubMed ID: 7519995
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Grb7 SH2 domain structure and interactions with a cyclic peptide inhibitor of cancer cell migration and proliferation.
    Porter CJ; Matthews JM; Mackay JP; Pursglove SE; Schmidberger JW; Leedman PJ; Pero SC; Krag DN; Wilce MC; Wilce JA
    BMC Struct Biol; 2007 Sep; 7():58. PubMed ID: 17894853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alternative mode of binding to phosphotyrosyl peptides by Src homology-2 domains.
    Qin C; Wavreille AS; Pei D
    Biochemistry; 2005 Sep; 44(36):12196-202. PubMed ID: 16142918
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.